Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI)
CUSIP: 89532M101
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 143,562,667
- Total 13F shares
- 7,161,506
- Share change
- -66,730
- Total reported value
- $15,754,000
- Price per share
- $2.20
- Number of holders
- 20
- Value change
- +$2,083,345
- Number of buys
- 12
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 89532M101?
CUSIP 89532M101 identifies TRVI - Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89532M101:
Top shareholders of TRVI - Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
4.1%
|
5,940,796
|
$4,634,000 | — | 31 Dec 2021 | |
| TPG GP A, LLC |
13F
|
Company |
3.4%
|
4,824,883
|
$3,774,000 | — | 31 Dec 2021 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1.1%
|
1,512,344
|
$1,183,000 | — | 31 Dec 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.24%
|
337,400
|
$264,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.1%
|
142,051
|
$111,000 | — | 31 Dec 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.08%
|
121,492
|
$95,000 | — | 31 Dec 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
75,000
|
$59,000 | — | 31 Dec 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
49,849
|
$39,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
49,077
|
$38,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.03%
|
44,948
|
$35,000 | — | 31 Dec 2021 | |
| WealthTrust Axiom LLC |
13F
|
Company |
0.02%
|
28,500
|
$22,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
11,414
|
$9,000 | — | 31 Dec 2021 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0.01%
|
10,461
|
$8,000 | — | 31 Dec 2021 | |
| LPL Financial LLC |
13F
|
Company |
0.01%
|
10,000
|
$8,000 | — | 31 Dec 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
8,317
|
$7,000 | — | 31 Dec 2021 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
3,500
|
$2,000 | — | 31 Dec 2021 |
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) as of Q1 2022
As of 31 Mar 2022,
Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,161,506 shares.
The largest 10 holders included
TPG GP A, LLC, MAI Capital Management, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, WealthTrust Axiom LLC, MILLENNIUM MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and BlackRock Inc..
This page lists
20
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
15
Q1 2022 holders
20
Holder diff
5
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.